Efficacy and safety of Chinese herbal footbaths for the treatment of dysmenorrhea: Protocol for a systematic review and meta-analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 22 08 2020
accepted: 30 03 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 15 10 2021
Statut: epublish

Résumé

Chinese herbal footbaths are an external therapy of traditional Chinese medicine that has been widely used to treat dysmenorrhea. This review aims to systematically evaluate its efficacy and safety for the treatment of dysmenorrhea. Databases of PubMed, EMBASE, Cochrane Library, CIHAHL, Web of Science, Chinese National Knowledge Infrastructure(CNKI), Chinese Scientific Journals Database (VIP), Wanfang Database, China Biomedical Literature Database(CBM), and Chinese Biomedical Literature Service System (SinoMed) will be searched from the inception to September 30, 2020. The eligible randomized controlled trials (RCTs) will be identified and included. The primary outcomes include pain intensity measured by validated scales of visual analog scale, numeric rating scale, and response rate of symptom reduction. The secondary outcomes are scores on validated pain questionnaires, quality of life measured by SF-36 or other validated scales, and adverse events. Study selection, data extraction, and assessment of bias risk will be conducted by two reviewers independently. RevMan software (V.5.3.5) will be utilized to perform data synthesis. Subgroup and sensitivity analysis will be performed when necessary. The strength of the evidence will be evaluated with the Grading of Recommendations Assessment, Development and Evaluation System. A high-quality synthesis of current evidence of Chinese herbal footbaths for patients with dysmenorrhea will be provided in this study. This systematic review will provide evidence of whether Chinese herbal footbaths are an effective and safe intervention for the treatment of dysmenorrhea. PROSPERO CRD42020188256.

Sections du résumé

BACKGROUND
Chinese herbal footbaths are an external therapy of traditional Chinese medicine that has been widely used to treat dysmenorrhea. This review aims to systematically evaluate its efficacy and safety for the treatment of dysmenorrhea.
METHODS
Databases of PubMed, EMBASE, Cochrane Library, CIHAHL, Web of Science, Chinese National Knowledge Infrastructure(CNKI), Chinese Scientific Journals Database (VIP), Wanfang Database, China Biomedical Literature Database(CBM), and Chinese Biomedical Literature Service System (SinoMed) will be searched from the inception to September 30, 2020. The eligible randomized controlled trials (RCTs) will be identified and included. The primary outcomes include pain intensity measured by validated scales of visual analog scale, numeric rating scale, and response rate of symptom reduction. The secondary outcomes are scores on validated pain questionnaires, quality of life measured by SF-36 or other validated scales, and adverse events. Study selection, data extraction, and assessment of bias risk will be conducted by two reviewers independently. RevMan software (V.5.3.5) will be utilized to perform data synthesis. Subgroup and sensitivity analysis will be performed when necessary. The strength of the evidence will be evaluated with the Grading of Recommendations Assessment, Development and Evaluation System.
RESULTS
A high-quality synthesis of current evidence of Chinese herbal footbaths for patients with dysmenorrhea will be provided in this study.
CONCLUSION
This systematic review will provide evidence of whether Chinese herbal footbaths are an effective and safe intervention for the treatment of dysmenorrhea.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO CRD42020188256.

Identifiants

pubmed: 33939740
doi: 10.1371/journal.pone.0250685
pii: PONE-D-20-26365
pmc: PMC8092769
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0250685

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Pediatr Adolesc Gynecol. 2014 Oct;27(5):258-65
pubmed: 24746919
Hum Reprod Update. 2015 Nov-Dec;21(6):762-78
pubmed: 26346058
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Cochrane Database Syst Rev. 2015 Jul 30;(7):CD001751
pubmed: 26224322
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002119
pubmed: 16855988
Evid Based Complement Alternat Med. 2014;2014:296860
pubmed: 25431607
J Pain. 2009 Jan;10(1):38-46
pubmed: 18722817
Psychopharmacol Bull. 1993;29(2):321-6
pubmed: 8290681
J Obstet Gynaecol Res. 2008 Dec;34(6):1049-53
pubmed: 19012707
Maturitas. 2016 Mar;85:19-26
pubmed: 26857875
Antioxidants (Basel). 2020 Oct 15;9(10):
pubmed: 33076228
F1000Res. 2017 Sep 5;6:1645
pubmed: 28944048
Nurse Pract. 2014 Nov 16;39(11):1-12
pubmed: 25325520
J Ethnopharmacol. 2016 Jun 20;186:234-243
pubmed: 27060631
Am Fam Physician. 2014 Mar 1;89(5):341-6
pubmed: 24695505
PLoS One. 2013 Nov 04;8(11):e72334
pubmed: 24223693
Anesthesiology. 2005 Jul;103(1):199-202
pubmed: 15983473
Int J Biometeorol. 2010 Jul;54(4):465-73
pubmed: 20157740
J Family Med Prim Care. 2018 Jul-Aug;7(4):769-774
pubmed: 30234051
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
J Clin Nurs. 2005 Aug;14(7):798-804
pubmed: 16000093
J Ethnopharmacol. 2014 Jul 3;154(3):696-703
pubmed: 24837303
BMJ. 2006 May 13;332(7550):1134-8
pubmed: 16690671
J Pediatr Adolesc Gynecol. 2013 Dec;26(6):350-4
pubmed: 24075089
Indian J Community Med. 2010 Jan;35(1):159-64
pubmed: 20606943
BMJ Open. 2019 Jun 27;9(6):e026186
pubmed: 31248919
J Clin Pharmacol. 2014 Mar;54(3):241-4
pubmed: 24374753
Epidemiol Rev. 2014;36:104-13
pubmed: 24284871
Int J Environ Res Public Health. 2020 Feb 13;17(4):
pubmed: 32069859
J Pharm Pharm Sci. 2013;16(5):821-47
pubmed: 24393558
J Phys Ther Sci. 2017 Aug;29(8):1292-1296
pubmed: 28878450
Int J Womens Health. 2016 Sep 19;8:489-496
pubmed: 27695366
J Obstet Gynaecol Can. 2017 Jul;39(7):585-595
pubmed: 28625286

Auteurs

Min Xiao (M)

College of Clinical Medicine/College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Lizhou Liu (L)

Centre for Health, Activity, and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, Otago, New Zealand.

Steve Tumilty (S)

Centre for Health, Activity, and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, Otago, New Zealand.

Dan Liu (D)

West China Hospital, Sichuan University, South Renmin Road, Wu Hou District, Chengdu, Sichuan, China.

Yanyan You (Y)

West China Hospital, Sichuan University, South Renmin Road, Wu Hou District, Chengdu, Sichuan, China.

Yunhui Chen (Y)

College of Clinical Medicine/College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Songqi Tang (S)

College of Traditional Chinese Medicine, Hainan Medical University, Haikou, Hainan, China.

Wei Huang (W)

College of Clinical Medicine/College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

George David Baxter (GD)

Centre for Health, Activity, and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, Otago, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH